{
    "clinical_study": {
        "@rank": "78787", 
        "arm_group": [
            {
                "arm_group_label": "Omacor\u00ae 4 g", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects in this group will take 4 g of Omacor\u00ae everyday."
            }, 
            {
                "arm_group_label": "Omacor\u00ae 2 g", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects in this group will take 2 g of Omacor\u00ae and 2 g of placebo everyday."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Subjects in this group will take 4 g of placebo everyday."
            }
        ], 
        "brief_summary": {
            "textblock": "1. Evaluation of the efficacy of Omacor\u00ae in Taiwanese hypertriglyceridemia patients\n\n        2. Evaluation of the safety of Omacor\u00ae in Taiwanese hypertriglyceridemia patients"
        }, 
        "brief_title": "An Efficacy and Safety Study of Omacor\u00ae in Taiwanese Hypertriglyceridemic Patients", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Hypertriglyceridemia", 
        "condition_browse": {
            "mesh_term": "Hypertriglyceridemia"
        }, 
        "detailed_description": {
            "textblock": "The primary end point is to evaluate the efficacy and safety of Omacor in Taiwanese\n      hypertriglyceridemia patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient has fasting serum TG \u2265 200 mg/dL but no more than 1000 mg/dL\n\n        Exclusion Criteria:\n\n          -  Patients had a history of pancreatitis or considered to be at risk of developing\n             pancreatitis\n\n          -  Patient had history of a severe cardiovascular event or a revascularization procedure\n             within 6 months prior to randomization"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "79 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "253", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 29, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01725646", 
            "org_study_id": "OM3-99001"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Omacor\u00ae 4 g", 
                    "Omacor\u00ae 2 g"
                ], 
                "description": "Subjects in 4 g and 2 g Omacor\u00ae will take this drug", 
                "intervention_name": "Omacor\u00ae", 
                "intervention_type": "Drug", 
                "other_name": "Omega-3-acid ethyl ester 90"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Subjects in placebo group will take this drug", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Olive oil"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Hypertriglyceridemia, omega-3-acid ethyl ester", 
        "lastchanged_date": "May 16, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Taichung", 
                        "country": "Taiwan", 
                        "zip": "40705"
                    }, 
                    "name": "Taichung Veterans General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tainan", 
                        "country": "Taiwan", 
                        "zip": "704"
                    }, 
                    "name": "National Cheng Kung University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taipei", 
                        "country": "Taiwan", 
                        "zip": "100"
                    }, 
                    "name": "National Taiwan University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taipei", 
                        "country": "Taiwan", 
                        "zip": "11217"
                    }, 
                    "name": "Taipei Veterans General Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Randomized, Double-blinded, Placebo-controlled Study to Assess the Efficacy and Safety of Omacor\u00ae in Taiwanese Hypertriglyceridemic Patients", 
        "overall_official": {
            "affiliation": "NTUH", 
            "last_name": "Chuen-Den Tseng, M.D., PhD.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Taiwan: Department of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change in Triglycerides from baseline", 
            "safety_issue": "Yes", 
            "time_frame": "baseline and 8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01725646"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Excelsior", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Excelsior", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}